1. Home
  2. NUVB vs THR Comparison

NUVB vs THR Comparison

Compare NUVB & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • THR
  • Stock Information
  • Founded
  • NUVB 2018
  • THR 1954
  • Country
  • NUVB United States
  • THR United States
  • Employees
  • NUVB N/A
  • THR N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • THR Industrial Machinery/Components
  • Sector
  • NUVB Health Care
  • THR Energy
  • Exchange
  • NUVB Nasdaq
  • THR Nasdaq
  • Market Cap
  • NUVB 1.1B
  • THR 829.9M
  • IPO Year
  • NUVB N/A
  • THR 2011
  • Fundamental
  • Price
  • NUVB $3.28
  • THR $26.43
  • Analyst Decision
  • NUVB Strong Buy
  • THR
  • Analyst Count
  • NUVB 6
  • THR 0
  • Target Price
  • NUVB $8.17
  • THR N/A
  • AVG Volume (30 Days)
  • NUVB 6.7M
  • THR 225.6K
  • Earning Date
  • NUVB 11-05-2025
  • THR 11-06-2025
  • Dividend Yield
  • NUVB N/A
  • THR N/A
  • EPS Growth
  • NUVB N/A
  • THR 9.96
  • EPS
  • NUVB N/A
  • THR 1.58
  • Revenue
  • NUVB $14,355,000.00
  • THR $491,979,000.00
  • Revenue This Year
  • NUVB $332.80
  • THR $3.24
  • Revenue Next Year
  • NUVB $360.12
  • THR $5.61
  • P/E Ratio
  • NUVB N/A
  • THR $16.64
  • Revenue Growth
  • NUVB 900.35
  • THR N/A
  • 52 Week Low
  • NUVB $1.54
  • THR $23.05
  • 52 Week High
  • NUVB $4.09
  • THR $33.25
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 58.18
  • THR 52.83
  • Support Level
  • NUVB $3.20
  • THR $25.12
  • Resistance Level
  • NUVB $3.41
  • THR $26.21
  • Average True Range (ATR)
  • NUVB 0.27
  • THR 0.87
  • MACD
  • NUVB -0.03
  • THR 0.12
  • Stochastic Oscillator
  • NUVB 33.55
  • THR 73.35

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.

Share on Social Networks: